Gossamer Bio (GOSS) Enterprise Value (2022 - 2025)
Gossamer Bio's Enterprise Value history spans 4 years, with the latest figure at -$121.4 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 58.78% year-over-year to -$121.4 million; the TTM value through Dec 2025 reached -$121.4 million, up 58.78%, while the annual FY2025 figure was -$121.4 million, 58.78% up from the prior year.
- Enterprise Value reached -$121.4 million in Q4 2025 per GOSS's latest filing, up from -$180.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$121.4 million in Q4 2025 to a low of -$354.5 million in Q2 2024.
- Average Enterprise Value over 4 years is -$239.8 million, with a median of -$256.8 million recorded in 2022.
- Peak YoY movement for Enterprise Value: tumbled 174.96% in 2024, then soared 58.78% in 2025.
- A 4-year view of Enterprise Value shows it stood at -$255.7 million in 2022, then fell by 15.94% to -$296.4 million in 2023, then rose by 0.64% to -$294.5 million in 2024, then skyrocketed by 58.78% to -$121.4 million in 2025.
- Per Business Quant, the three most recent readings for GOSS's Enterprise Value are -$121.4 million (Q4 2025), -$180.2 million (Q3 2025), and -$212.9 million (Q2 2025).